CLINICAL TRIALS PROFILE FOR ETOMIDATE
✉ Email this page to a colleague
All Clinical Trials for ETOMIDATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00175747 ↗ | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | Completed | National Cancer Institute (NCI) | Phase 2/Phase 3 | 2000-01-01 | Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia. |
NCT00175747 ↗ | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | Completed | University of British Columbia | Phase 2/Phase 3 | 2000-01-01 | Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia. |
NCT00248729 ↗ | Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital. | Completed | St. Luke's Hospital, Pennsylvania | Phase 2 | 2002-10-01 | The objective of this study was to compare the utility of etomidate and midazolam in helping patients to relax when there was a need for the placement of a ventilation tube by medics who were transporting patients to a hospital in an ambulance. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ETOMIDATE
Condition Name
Clinical Trial Locations for ETOMIDATE
Trials by Country
Clinical Trial Progress for ETOMIDATE
Clinical Trial Phase
Clinical Trial Sponsors for ETOMIDATE
Sponsor Name